Expert Insights for Health Science Companies
As a global leader in health science M&A, recapitalization, and growth financing strategies, Crosstree has led 100+ transactions for companies at the center of this fast-moving industry.
Positioning Biobanking Assets for Maximum Value
Leveraging the Precision Medicine Opportunity for Biobanks.
September 9, 2021
As precision medicine grows, so, too, does demand for biobanking services. In this white paper, learn how to evaluate biobank platforms and develop growth strategies that leverage the market shift towards precision medicine.
Read White PaperPharma Services April 2022
Clarify Health Solutions has raised $165mm in a round of funding led by SoftBank Vision Fund 2 Biofourmis Singapore has...
Diagnostics & Tools April 2022
Groupe Bruxelles Lambert (GBL) has agreed to acquire Affidea for approximately $1bb bioMérieux has agreed to acquire Specific Diagnostics for...
Pharma Services March 2022
ConcertAI has raised $150mm in a round of funding led by Sixth Street Partners North American Science Associates has acquired...
Diagnostics & Tools March 2022
Grenova has received funding from Peloton Equity BillionToOne has received $125mm in funding in a round led by Adams Street...
